[Funding alert] Tilak Healthcare Secures €10M in Funding to Gamify Eye Disease Monitoring

Read also - Insulation Startup VARM Secures a Seven-Figure Pre-Seed Round of Funding

OdySight, a Class I medical device with a CE mark, was developed by Tilak Healthcare. The method is the first remote monitoring system for ocular disorders, particularly ongoing macular degeneration, which is the primary cause of blindness in persons under 50 and is a condition that is growing rapidly in prevalence.

Read also - London-based Travel Startup Fly Now Pay Later Secures $180M in Funding

It contains a mobile gaming experience made to remotely assess vision deficits brought on by aging. Its first platform, called OdySight, focuses on ophthalmology. OdySight improves the patient treatment procedure and is the industry standard for home visually monitoring.

Read also - German-based Digital Insurtech Startup Getsafe has Acquired the Portfolio of Luko

Edouard Gasser, Chairman, CEO and co-founder of Tilak Healthcare said: “All our investors share our ambition of revolutionising ophthalmological care through digital technologies and video games, helping to address some of the problems all healthcare systems worldwide are facing. We have recently hit key milestones in our quest to make Tilak Healthcare a global benchmark for remotely monitoring vision impairments.
Visual health is one of the keys to ageing well, and we intend to apply our expertise to help people maintain their vision as best as possible.”

The total amount of investment for Tilak Healthcare is currently at €22 million. The money will be utilized for investigating new treatments for various medical ailments as well as to speed up the delivery of OdySight both domestically and abroad.

Read also - London-based fintech Startup Untangled Raises €12.8 million in Funding

Longtime investors iBionext and SWEN Capital Partners, Théa (the leader in the French ophthalmology market), Adelie, and an array of renowned ophthalmologists and business angels, notably Yann Fleureau (co-founder of Cardiologs), joined Elaia and Cap Horn in the financing effort.

Read also - Luxembourg-based Ecommerce Platform MarketLeap Secures €1.5 million in Seed Funding

Samantha Jérusalmy, Partner at Elaia, shared, Visual health is one of the keys to ageing well, and we intend to apply our expertise to help people maintain their vision as best as possible. Tilak Healthcare is establishing itself as a leading player in visual health by introducing new ways of monitoring patients with OdySight®, the first clinically proven app for monitoring chronic vision impairments remotely. Tilak has made impressive progress since we first invested, and is on track to meet the growing need for monitoring vision impairments due to new lifestyles and ageing populations.”

Fabrice Mercier, Alliance Manager at Théa, added: “Théa is looking forward to increasing its support to Tilak Healthcare, continuing our successful collaboration in launching OdySight® in France. This commitment emphasises our aim of pursuing therapeutic advances that meet the needs of both patients and healthcare professionals. At Théa, we are fully committed to fostering innovation in collaboration with all participants in the healthcare ecosystem, with the ambition of eliminating avoidable blindness and proposing solutions that improve the quality of life of people living with eye disorders.”

About Tilak Healthcare

At Tilak, they use gaming with a purpose to change the way they keep track of long-term eye issues. Their objective is to equip patients with enjoyable and simple-to-use apps that will aid in enhanced disease management for both them and their doctors. It says, "You Play, We Care."

Read also - Italian Aquaponic firm The Circle Raises €2.1M in Funding